Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quanam Medical was a U.S. medical device company focused on polymer-based intravascular stent technologies and drug-device concepts for vascular interventions. Patent records associated with the company describe memory-polymer stents and polymer compositions for intraluminal stents, as well as approaches using topoisomerase inhibitors for prevention of restenosis. Corporate registry data indicate the company later became associated with Boston Scientific, suggesting it was acquired rather than remaining an independent operating company. Public evidence of an active standalone commercial business is limited, and the company appears to be historical rather than currently operating as an independent biotech or medtech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quanam Medical.